EBNEO Commentary: The LAKANA Trial: Mass Administration of Azithromycin to Infants in Mali Did Not Reduce Mortality
Maya I Brasher1, Monika S Patil1
1Department of Pediatrics, Section of Neonatology, Baylor College of Medicine, Houston, USA.
Acta Paediatrica (Oslo, Norway : 1992)
|March 12, 2026
Abstract:
The LAKANA trial: a randomized control trial evaluating the impact of mass administration of azithromycin to infants 1 to 11 months of age in Mali showed no reduction in mortality.
More Related Videos
10:19Establishment and Optimization of a High Throughput Setup to Study Staphylococcus epidermidis and Mycobacterium marinum Infection as a Model for Drug Discovery
Published on: June 26, 2014
13.7K
06:49Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians
Published on: March 14, 2014
12.1K
